This information was published on 2025-09-23T13:55:17 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2587758 (IR 1875821) |
| (220) |
03 Jun 2025
|
| (300) |
CH, 22 Apr 2025, 831384
|
| (511) (510) |
Class 1
Cells and chemical preparations for scientific research in the fields of immunotherapy and oncology. Class 5 Pharmaceutical preparations and biological preparations for the treatment of immune system related and oncological diseases and disorders; Biological diagnostic preparations for medical use. Class 44 Medical services, namely, modifying cells for the treatment of immune system related and oncological diseases and disorders; Immunotherapy treatments; medical diagnostic and treatment services; providing information in the field of oncology and immunotherapy treatments; providing medical information, consultancy and advisory services. |
| (540) |
|
| (550) | Figurative |
| (730) |
Iovance Biotherapeutics GmbH
|
Find out more about publications on the About page.